| CMS keeps status quo on Amgen's anemia meds - FiercePharma |
|
|
FiercePharma Epogen is one of three erythropoiesis stimulating agents used to treat kidney patients, but it's the only one approved for use in patients already undergoing dialysis. And it was the use of ESAs in dialysis patients that had been open for debate. |